US Archives - Page 91 of 99 - European Medical Journal

Ozanimod Long-Term Safety and Efficacy

S1P receptor 1 and 5 modulator for relapsing forms of MS in adults, including clinically isolated syndrome, relapsing-remitting disease…

New Frontiers in Alzheimer’s Disease

THIS YEAR’s American Academy of Neurology (AAN) Annual Meeting, held in Denver, Colorado, USA, from April 13–18, featured an insightful…

Emerging Neuroinfectious Diseases

Delve into research regarding newly recognized pathogens, and the challenges they present to global health. Discussions explored a range…

EMJ

Dr Simy Parikh

Dr Simy Parikh – Program Director, Advanced Headache Diagnosis & Management and Assistant Professor, Department of Neurology, Jefferson…

EMJ

Dr Giuseppe Lanza

Dr Giuseppe Lanza – Consultant Neurologist and Clinical Researcher, Department of Neurology I.C., Oasi Institute for Research on Mental…

EMJ

Prof Nils Erik Gilhus

Prof Nils Erik Gilhus – Professor and Consultant in Neurology, University of Bergen; Haukeland University Hospital, Bergen, Norway…

EMJ

Dr Natan Bornstein

Director, Brain Division, Shaare-Zedek Medical Center, Jerusalem, Israel; Vice President, World Stroke Organization (WSO)…

EMJ

Prof Amos Korczyn

Prof Amos Korczyn – Professor Emeritus of Neurology and Pharmacology, Tel-Aviv University, Tel Aviv, Israel; Chairman, Controversies in…

Interview: Jacqueline A. French

I feel like epilepsy is the ‘window’ into the brain, because when people have a seizure, their onset tells you a lot about that area of…

Movement Disorder: Initial Manifestation of Hereditary Hemochromatosis – A Case Report

Hemochromatosis is a genetic disorder characterized by pathological tissue iron deposition with multiple organ involvement…